Novo Nordisk is committed to helping more patients reach their growth potential. Norditropin ® is the only growth hormone approved for children who are short in stature and who have Noonan …

Norditropin ® is a prescription medicine that contains human growth hormone and is used to treat: children who are not growing because of low or no growth hormone children who are short (in …

Jun 1, 2019 · Imagine the possibilities with Sogroya ®, the first and only once-weekly growth hormone (GH) treatment for pediatric patients aged 2.5 years and older with growth failure due …

Introduction and information about growth hormone and growth disorders and the current research we are conducting to find newer and better treatments for people living with the disease.

Monitor patients carefully for increased growth, or potential malignant changes, of preexisting nevi. Glucose intolerance and diabetes mellitus: Treatment with somatropin may decrease …

Learn about Norditropin®, a growth hormone therapy approved for 7 indications and see how it works to treat patients with growth-related disorders. Read Important Safety and Prescribing Info.

Growth hormone (GH) helps promote growth in children. It is important for growth, muscle and bone strength, and distribution of body fat. 1,2 Once the growth plates in your bones …

Apr 28, 2023 · Novo Nordisk plans to make Sogroya ® available for both pediatric and adult patients in the coming months. What is Sogroya®? Sogroya ® (somapacitan-beco) injection 5 …

Growth hormone therapy (GHT) is a biosynthetic hormone replacement therapy that is administered subcutaneously. If a child is not growing as they should, early detection of the …

Sogroya® (somapacitan-beco) injection is a once-weekly growth hormone injection used to treat children aged 2.5 years or older and adults with growth hormone deficiency (GHD). Read …